1620 Investment Advisors’s Allena Pharmaceuticals ALNA Stock Holding History

1620 Investment Advisors’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,000	Closed	–	–	137
2022 Q3	$0	Hold	15,000	–	–	﹤0.01%	134
2022 Q2	$3K	Buy	+15,000	New	+$2.32K	﹤0.01%	125

1620 Investment Advisors's ALNA Position: Q4 2022 in Review

1620 Investment Advisors sold out of Allena Pharmaceuticals (ALNA) in Q4 2022, closing a stake of 15,000 shares.

1620 Investment Advisors first reported a position in ALNA in Q2 2022 and held it in 2 quarters. The position peaked at $3K in Q2 2022. 0 funds tracked by Wall St. Rank hold ALNA as of Q4 2022.

1620 Investment Advisors reported no remaining Allena Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
1620 Investment Advisors sold 15,000 Allena Pharmaceuticals shares in Q4 2022.
1620 Investment Advisors first reported a position in Allena Pharmaceuticals in Q2 2022 and held it in 2 quarters.
1620 Investment Advisors's Allena Pharmaceuticals position peaked at $3K in Q2 2022.
0 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2022.

Based on 1620 Investment Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.